Home > Boards > US Listed > Biotechs > Cel-Sci (CVM)

There is a "buyout rumor" circulating right now,

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Superfly15 Member Profile
 
Followed By 40
Posts 2,710
Boards Moderated 0
Alias Born 03/23/10
160x600 placeholder
Current Report Filing (8-k) "Edgar (US Regulatory)" - 7/23/2014 11:36:56 AM
CEL-SCI Receives Regulatory Clearance to Expand Phase III Head and Neck Cancer Trial into Turkey "Business Wire" - 7/22/2014 8:30:00 AM
CEL-SCI Expands Its Phase III Head and Neck Cancer Trial into Sri Lanka "Business Wire" - 7/17/2014 8:45:00 AM
CEL-SCI Receives $225,000 NIH Research Grant to Develop Rheumatoid Arthritis Treatment "Business Wire" - 7/15/2014 8:00:00 AM
CEL-SCI Presents Rheumatoid Arthritis Data at the 12th Vaccines Research & Development: All Things Considered Conference "Business Wire" - 7/11/2014 9:00:00 AM
Notice of Effectiveness (effect) "Edgar (US Regulatory)" - 7/9/2014 6:00:28 AM
CEL-SCI Receives Regulatory Clearance to Expand CEL-SCI’S Phase III Head and Neck Cancer Trial into Austria "Business Wire" - 7/8/2014 8:15:00 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) "Edgar (US Regulatory)" - 7/3/2014 6:00:38 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 7/1/2014 9:16:36 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 7/1/2014 9:12:54 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 7/1/2014 9:08:38 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 7/1/2014 9:05:26 AM
CEL-SCI Reports 93% Increase in Sequential Quarterly Patient Enrollment in Its Phase III Head and Neck Cancer Trial "Business Wire" - 7/1/2014 8:30:00 AM
Securities Registration Statement (simplified Form) (s-3/a) "Edgar (US Regulatory)" - 6/20/2014 4:55:41 PM
CEL-SCI to Present at the 2014 BIO International Convention "Business Wire" - 6/18/2014 9:00:00 AM
CEL-SCI Reports Continued Increase in Sequential Quarterly Patient Enrollment in Its Phase III Head and Neck Cancer Trial "Business Wire" - 6/3/2014 8:30:00 AM
CEL-SCI Receives Approval to Expand Its Immunotherapy Phase III Head and Neck Cancer Trial into the United Kingdom "Business Wire" - 6/2/2014 9:30:00 AM
Proxy Statement (definitive) (def 14a) "Edgar (US Regulatory)" - 5/30/2014 5:22:37 PM
University of Cincinnati Cancer Institute’s Comprehensive Head and Neck Cancer Center Joins CEL-SCI’S Phase III Trial "Business Wire" - 5/27/2014 8:00:00 AM
Securities Registration Statement (simplified Form) (s-3) "Edgar (US Regulatory)" - 5/23/2014 4:15:03 PM
CEL-SCI Corporation Reports Second Quarter Fiscal 2014 Financial Results "Business Wire" - 5/13/2014 8:00:00 AM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 5/12/2014 4:19:59 PM
CEL-SCI Reports April 2014 is Another Record Month for Patient Enrollment in Its Phase III Head and Neck Cancer Trial "Business Wire" - 5/1/2014 8:00:00 AM
CEL-SCI Corporation Receives $3 Million from Warrant Exercises "Business Wire" - 4/29/2014 8:30:00 AM
Southern Illinois University School of Medicine Becomes Clinical Site for CEL-SCI’s Global Phase III Immunotherapy Head & N... "Business Wire" - 4/28/2014 8:30:00 AM
Superfly15   Tuesday, 09/21/10 12:38:34 PM
Re: roger wilco post# 3591
Post # of 6193 
There is a "buyout rumor" circulating right now, they probably need some cash. I wouldnt chase this POS thats just me.

http://bit.ly/apwiVN

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist